No Data
No Data
Express News | HC Wainwright & Co. Maintains Buy on BioCardia, Adjusts Price Target To $25 (1-15 Reverse Stock Split)
Earnings Call: BioCardia Reports Progress in Heart Failure Trials
Earnings Call Summary | BioCardia(BCDA.US) Q2 2024 Earnings Conference
Express News | BioCardia Inc : H.c. Wainwright Adjusts Target Price to $25 From $4 to Reflect 1-for-15 Reverse Stock Split
BioCardia, Inc. (BCDA) Q2 2024 Earnings Call Transcript
Express News | BioCardia Inc- Qtrly Shr Loss $0.88
No Data